Cohort Studies Suggesting Immediate HAART Confers No Extra Benefit Compared with Deferred HAART in HIV-Infected Persons CD4 >200 cells/mm3

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

HIV Medications: When to Start and What to Take -- A Guide From TheBody.com

Treatment Action Group

Cohort Studies Suggesting Immediate HAART Confers No Extra Benefit Compared with Deferred HAART in HIV-Infected Persons CD4 >200 cells/mm³

March 2000

Study	N	Reference
EuroSIDA	7,331	Phillips, 1999
Swiss Cohort	3,342	AIDS, 1999
ICONA (Italy)	805	Phillips, 1999
Frankfurt Cohort	536	Phillips, 1999
Royal Free	500	Phillips, 1999
Hemophilia Cohort

Back to the TAGline March, 2000 contents page.

HIV Medications: When to Start and What to Take -- A Guide From TheBody.com

This article was provided by Treatment Action Group. It is a part of the publication TAGline.

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.